Vijaya Diagnostic Centre Limited (VIJAYA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.160x

Based on the latest financial reports, Vijaya Diagnostic Centre Limited (VIJAYA) has a cash flow conversion efficiency ratio of 0.160x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.39 Billion ≈ $14.99 Million USD) by net assets (Rs8.65 Billion ≈ $93.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Vijaya Diagnostic Centre Limited net asset quality index to measure how much of total assets are equity-financed.

Vijaya Diagnostic Centre Limited - Cash Flow Conversion Efficiency Trend (2019–2026)

This chart illustrates how Vijaya Diagnostic Centre Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check VIJAYA cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Vijaya Diagnostic Centre Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vijaya Diagnostic Centre Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
BlackRock ESG Capital Allocation Trust NYSE:ECAT	N/A
Sylvamo Corp NYSE:SLVM	-0.010x
Chongqing Iron & Steel Co Ltd Class A SHG:601005	0.058x
SIGMAROC PLC LS -01 F:M2I2	N/A
Zhongmin Energy Co Ltd SHG:600163	0.012x
Zoomlion Heavy Industry Science and Technology Co. Ltd F:8CZ	0.019x
FAP Agri Tbk PT JK:FAPA	0.099x
Ta Liang Technology Co Ltd TW:3167	0.117x

Annual Cash Flow Conversion Efficiency for Vijaya Diagnostic Centre Limited (2019–2026)

The table below shows the annual cash flow conversion efficiency of Vijaya Diagnostic Centre Limited from 2019 to 2026. For the full company profile with market capitalisation and key ratios, see market value of Vijaya Diagnostic Centre Limited.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs9.57 Billion ≈ $103.51 Million	Rs2.71 Billion ≈ $29.26 Million	0.283x	+0.65%
2025-03-31	Rs7.99 Billion ≈ $86.42 Million	Rs2.24 Billion ≈ $24.28 Million	0.281x	+1.13%
2024-03-31	Rs6.60 Billion ≈ $71.37 Million	Rs1.83 Billion ≈ $19.82 Million	0.278x	-7.76%
2023-03-31	Rs5.47 Billion ≈ $59.12 Million	Rs1.65 Billion ≈ $17.80 Million	0.301x	-10.51%
2022-03-31	Rs4.70 Billion ≈ $50.78 Million	Rs1.58 Billion ≈ $17.09 Million	0.336x	-6.76%
2021-03-31	Rs3.59 Billion ≈ $38.85 Million	Rs1.30 Billion ≈ $14.02 Million	0.361x	-6.76%
2020-03-31	Rs2.74 Billion ≈ $29.65 Million	Rs1.06 Billion ≈ $11.48 Million	0.387x	-11.49%
2019-03-31	Rs2.07 Billion ≈ $22.39 Million	Rs905.27 Million ≈ $9.79 Million	0.437x	--

About Vijaya Diagnostic Centre Limited

NSE:VIJAYA India Diagnostics & Research

Market Cap

$1.51 Billion

Rs139.32 Billion INR

Market Cap Rank

#7100 Global

#348 in India

Share Price

Rs1354.00

Change (1 day)

+0.71%

52-Week Range

Rs861.40 - Rs1412.50

All Time High

Rs1412.50